Exor Earnings Call: Buybacks, Lingotto Surge, NAV Strain

Exor N.V. (OTC) ((NL:EXO)) has held its Q4 earnings call. Read on for the main highlights of the call.

Exor’s latest earnings call struck a cautiously balanced tone, pairing strong internal execution with visible market headwinds. Management highlighted Lingotto’s standout performance, aggressive buybacks and a fortified balance sheet, but acknowledged pressure from key listed holdings, a steep discount to NAV and a tougher backdrop heading into 2026.

Lingotto’s EUR 10 Billion AUM and 40% Surge

Lingotto has become a central bright spot, reaching about EUR 10 billion in assets under management and delivering roughly 40% performance in 2025. Management credited the gains to its intersection/public strategy and disciplined use of selective third‑party capital, reinforcing Lingotto as a core growth engine.

Buybacks at Deep Discount Drive Per-Share Accretion

Exor intensified capital returns through a EUR 1 billion share repurchase in 2025, executed at a discount above 50% to NAV. Cumulatively, around EUR 2.5 billion of stock has been bought back in recent years, shrinking the share count by close to 15% and supporting accretive growth in per‑share metrics.

Robust Liquidity and De-Risked Balance Sheet

The group closed FY 2025 with EUR 1.4 billion in cash, a doubled EUR 1.1 billion credit facility and a low 6.9% loan‑to‑value ratio, underpinned by modest near‑term maturities. Management expects roughly EUR 3 billion of additional cash from announced deals, putting potential liquidity near EUR 4 billion and reinforcing financial flexibility.

Lingotto Model Validates Return-Focused Strategy

Executives framed Lingotto’s performance as proof of Exor’s investment philosophy, which emphasizes returns over pure asset gathering. Exor participates not only as the majority owner of the asset manager but also via co‑investment, allowing shareholders to benefit from both fee income and investment upside.

Philips Execution Improves and Ambition Rises

Philips delivered margin expansion in 2025 alongside a peak in order intake, signaling better operational momentum at a key holding. Exor lifted its economic interest to about 19%, while Philips outlined a 2026–2028 plan targeting mid‑single‑digit sales growth and mid‑teens margins, underscoring rising confidence in the turnaround.

Iveco Deals Unlock Value and Near-Term Cash

Portfolio reshaping continued through Iveco, which closed the sale of its Defence business to Leonardo and advanced a combination of its remaining operations with Tata Motors. The two transactions carry a total valuation of EUR 5.3 billion and are expected to deliver near‑term dividends, adding to Exor’s cash war chest.

NAV Per Share Decline Highlights Market Headwinds

Despite internal progress, NAV per share slipped from EUR 178 to EUR 164.4 in 2025, a decline of about 7.6%. Management stressed that the drop, equivalent to roughly EUR 13.6 per share, reflects market‑driven weakness in key holdings more than structural erosion of intrinsic value.

Ferrari, Stellantis and CNH Concentrate the Pain

Three core positions – Ferrari, Stellantis and CNH – were the main drag, together responsible for an estimated EUR 25 per share hit to NAV. The concentration of negative impact underscores Exor’s exposure to a handful of large industrial and automotive assets, amplifying volatility despite portfolio diversification efforts.

Stellantis Faces Reset Under New Leadership

Stellantis encountered a mix of external pressures and internal execution issues during 2025, prompting a strategic reset under new management. Exor signaled that 2026 will be pivotal, with a Capital Markets Day planned for late May, but also warned that execution risks remain elevated as the turnaround unfolds.

CNH Grapples With Downcycle and Quality Issues

CNH is battling a deep agricultural downturn compounded by geopolitical and tariff headwinds and product quality concerns. Management expects the pressure to extend into 2026 and flagged the need for margin repair and quality remediation, suggesting a multi‑year path before the asset can fully recover.

Persistent Deep Discount to NAV Frustrates Shareholders

Exor’s shares continue to trade at a hefty discount to NAV, repeatedly described on the call as well above 50%. While buybacks at such levels are mathematically attractive, the persistent gap is weighing on total shareholder returns and complicating the market’s perception of Exor’s underlying progress.

Unlisted Portfolio Shows Mixed, Idiosyncratic Outcomes

Performance across unlisted holdings remained uneven, with some assets like Welltec delivering an exceptional year and others such as Shang Xia still struggling. This dispersion adds idiosyncratic volatility to results and highlights the execution challenge of managing a diverse private portfolio alongside large listed stakes.

Guidance: Cautious, Liquidity-First Capital Allocation in 2026

Looking ahead, management guided to a cautious, liquidity‑first stance after a heavy year of portfolio reshaping and buybacks, anchored by low leverage and sizeable cash. Priorities include focusing on larger holdings, simplifying the portfolio and deploying capital selectively in areas like healthcare, luxury and technology, with a willingness to take meaningful stakes when risk‑reward is compelling.

Exor’s earnings call painted a picture of a holding company strengthening its internal engines while enduring turbulence in some of its flagship investments. For investors, the case now rests on whether disciplined capital allocation, Lingotto’s momentum and a powerful balance sheet can offset cyclical and company‑specific pressures as the group navigates a challenging 2026.